Skip to content

A research study to look at how CagriSema influences food intake, appetite and emptying of the stomach in people with excess body weight

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-504792-24-00
Acronym
NN9838-4695
Enrollment
60
Registered
2024-01-09
Start date
2024-02-20
Completion date
2024-11-22
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

None listed

Sponsors

Novo Nordisk A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026